{"id":77596,"date":"2012-10-29T15:33:00","date_gmt":"2012-10-29T15:33:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/"},"modified":"2012-10-29T15:33:00","modified_gmt":"2012-10-29T15:33:00","slug":"nova-guia-de-seguiment-farmacoterapeutic-amb-spd","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/","title":{"rendered":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD"},"content":{"rendered":"

\u00a0<\/p>\n

\u00a0Una nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD contribuir\u00e0 a optimitzar els resultats d\u2019adher\u00e8ncia farmacoterap\u00e8utica dels malalts cr\u00f2nics<\/strong><\/p>\n

29\/10\/2012.- La nova Guia de Seguiment Farmacoterap\u00e8rutic amb Sistemes Personalitzats de Dosificaci\u00f3 (SPD), elaborada per representants del Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya i del Departament de Salut de la Generalitat,\u00a0contribuir\u00e0<\/strong>\u00a0a millorar l’optimitzaci\u00f3 de resultats terap\u00e8utics als usuaris del servei<\/strong>. La Guia proporciona les eines perqu\u00e8 les farm\u00e0cies reuneixin els requisits per preparar els SPD dins del servei de Seguiment Farmacoterap\u00e8utic, fet que permetr\u00e0 avaluar els seus resultats.<\/p>\n

Garantia de millora en la salut del pacient<\/strong><\/p>\n

Despr\u00e9s de m\u00e9s de dotze anys proporcionant sistemes personalitzats de dosificaci\u00f3 als pacients per optimitzar l’adher\u00e8ncia als tractaments, s’ha fet un pas endavant per integrar aquesta activitat dins del servei de seguiment farmacoterap\u00e8utic, d’acord al marc legal establert per la Llei de Garanties, modificada pel Reial decret Llei 9\/2011.<\/p>\n

Aix\u00ed, la nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD actualitza el procediment de treball que ja tenien establerts els col\u00b7legis i emmarca aquest servei professional dins de la normativa actual. A m\u00e9s, estableix els sistemes personalitzats de dosificaci\u00f3 com a eina de millora a l’adher\u00e8ncia al tractament en els pacients als quals se’ls est\u00e0 realitzant el seguiment farmacoterap\u00e8utic.<\/p>\n

Aquesta Guia es considera el punt de partida per al registre de les intervencions dels farmac\u00e8utics que ja proporcionen el servei, i a m\u00e9s \u00e9s el pas previ a la possible concertaci\u00f3 d’aquest servei en determinats pacients. Amb aquesta Guia es pret\u00e9n garantir un mateix servei de qualitat a tots els usuaris que rebin el seguiment farmacoterap\u00e8utic amb SPD.<\/p>\n

La Guia s’ha presentat als farmac\u00e8utics catalans i estableix un per\u00edode d’adaptaci\u00f3 per aquells farmac\u00e8utics que actualment ja estan proporcionant el servei. Aquest per\u00edode d’adaptaci\u00f3 inclou l’actualitzaci\u00f3 de la formaci\u00f3 i el procediment de l’autoritzaci\u00f3 administrativa.<\/p>\n

Per a m\u00e9s informaci\u00f3<\/strong>:
Departament de Comunicaci\u00f3\u00a0
premsa@cofb.net<\/a>\u00a0
93 244 07 28\/18<\/p>\n

\u00a0\u00a0Una nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD contribuir\u00e0 a optimitzar els resultats d\u2019adher\u00e8ncia farmacoterap\u00e8utica dels malalts cr\u00f2nics29\/10\/2012.- La nova Guia de Seguiment Farmacoterap\u00e8rutic amb Sistemes Personalitzats de Dosificaci\u00f3 (SPD), elaborada per representants del Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya i del Departament de Salut de la Generalitat,\u00a0contribuir\u00e0\u00a0a millorar l’optimitzaci\u00f3 de resultats terap\u00e8utics als usuaris del servei. La Guia proporciona les eines perqu\u00e8 les farm\u00e0cies reuneixin els requisits per preparar els SPD dins del servei de Seguiment Farmacoterap\u00e8utic, fet que permetr\u00e0 avaluar els seus resultats.Garantia de millora en la salut del pacientDespr\u00e9s de m\u00e9s de dotze anys proporcionant sistemes personalitzats de dosificaci\u00f3 als pacients per optimitzar l’adher\u00e8ncia als tractaments, s’ha fet un pas endavant per integrar aquesta activitat dins del servei de seguiment farmacoterap\u00e8utic, d’acord al marc legal establert per la Llei de Garanties, modificada pel Reial decret Llei 9\/2011.Aix\u00ed, la nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD actualitza el procediment de treball que ja tenien establerts els col\u00b7legis i emmarca aquest servei professional dins de la normativa actual. A m\u00e9s, estableix els sistemes personalitzats de dosificaci\u00f3 com a eina de millora a l’adher\u00e8ncia al tractament en els pacients als quals se’ls est\u00e0 realitzant el seguiment farmacoterap\u00e8utic.Aquesta Guia es considera el punt de partida per al registre de les intervencions dels farmac\u00e8utics que ja proporcionen el servei, i a m\u00e9s \u00e9s el pas previ a la possible concertaci\u00f3 d’aquest servei en determinats pacients. Amb aquesta Guia es pret\u00e9n garantir un mateix servei de qualitat a tots els usuaris que rebin el seguiment farmacoterap\u00e8utic amb SPD.La Guia s’ha presentat als farmac\u00e8utics catalans i estableix un per\u00edode d’adaptaci\u00f3 per aquells farmac\u00e8utics que actualment ja estan proporcionant el servei. Aquest per\u00edode d’adaptaci\u00f3 inclou l’actualitzaci\u00f3 de la formaci\u00f3 i el procediment de l’autoritzaci\u00f3 administrativa.Per a m\u00e9s informaci\u00f3:Departament de Comunicaci\u00f3\u00a0premsa@cofb.net\u00a093 244 07 28\/18\u00a0\u00a0COFB.ORG<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00a0 \u00a0Una nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD contribuir\u00e0 a optimitzar els resultats d\u2019adher\u00e8ncia farmacoterap\u00e8utica dels malalts cr\u00f2nics 29\/10\/2012.- La nova Guia de Seguiment Farmacoterap\u00e8rutic amb Sistemes Personalitzats de Dosificaci\u00f3 (SPD), elaborada per representants del Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya i del Departament de Salut de la Generalitat,\u00a0contribuir\u00e0\u00a0a […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77596","post","type-post","status-publish","format-standard","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"\nNova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 \u00a0Una nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD contribuir\u00e0 a optimitzar els resultats d\u2019adher\u00e8ncia farmacoterap\u00e8utica dels malalts cr\u00f2nics 29\/10\/2012.- La nova Guia de Seguiment Farmacoterap\u00e8rutic amb Sistemes Personalitzats de Dosificaci\u00f3 (SPD), elaborada per representants del Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya i del Departament de Salut de la Generalitat,\u00a0contribuir\u00e0\u00a0a […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2012-10-29T15:33:00+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Nova guia de seguiment farmacoterap\u00e8utic amb SPD\",\"datePublished\":\"2012-10-29T15:33:00+00:00\",\"dateModified\":\"2012-10-29T15:33:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\"},\"wordCount\":705,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\",\"name\":\"Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"datePublished\":\"2012-10-29T15:33:00+00:00\",\"dateModified\":\"2012-10-29T15:33:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nova guia de seguiment farmacoterap\u00e8utic amb SPD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/","og_locale":"ca_ES","og_type":"article","og_title":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 \u00a0Una nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD contribuir\u00e0 a optimitzar els resultats d\u2019adher\u00e8ncia farmacoterap\u00e8utica dels malalts cr\u00f2nics 29\/10\/2012.- La nova Guia de Seguiment Farmacoterap\u00e8rutic amb Sistemes Personalitzats de Dosificaci\u00f3 (SPD), elaborada per representants del Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya i del Departament de Salut de la Generalitat,\u00a0contribuir\u00e0\u00a0a […]","og_url":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2012-10-29T15:33:00+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD","datePublished":"2012-10-29T15:33:00+00:00","dateModified":"2012-10-29T15:33:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/"},"wordCount":705,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/","url":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/","name":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"datePublished":"2012-10-29T15:33:00+00:00","dateModified":"2012-10-29T15:33:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 \u00a0Una nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD contribuir\u00e0 a optimitzar els resultats d\u2019adher\u00e8ncia farmacoterap\u00e8utica dels malalts cr\u00f2nics 29\/10\/2012.- La nova Guia de Seguiment Farmacoterap\u00e8rutic amb Sistemes Personalitzats de Dosificaci\u00f3 (SPD), elaborada per representants del Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya i del Departament de Salut de la Generalitat,\u00a0contribuir\u00e0\u00a0a […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=77596"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77596\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=77596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=77596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=77596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}